Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Anti-melanoma efficacy of internal radionuclide therapy in relation to melanin target distribution.

Bonnet M, Mishellany F, Papon J, Cayre A, Penault-Llorca F, Madelmont JC, Miot-Noirault E, Chezal JM, Moins N.

Pigment Cell Melanoma Res. 2010 Oct;23(5):e1-11. doi: 10.1111/j.1755-148X.2010.00716.x. Epub 2010 Apr 22.

PMID:
20444199
2.

Targeted radionuclide therapy of melanoma: anti-tumoural efficacy studies of a new 131I labelled potential agent.

Bonnet-Duquennoy M, Papon J, Mishellany F, Labarre P, Guerquin-Kern JL, Wu TD, Gardette M, Maublant J, Penault-Llorca F, Miot-Noirault E, Cayre A, Madelmont JC, Chezal JM, Moins N.

Int J Cancer. 2009 Aug 1;125(3):708-16. doi: 10.1002/ijc.24413.

3.

[¹²³I]ICF01012 melanoma imaging and [¹³¹I]ICF01012 dosimetry allow adapted internal targeted radiotherapy in preclinical melanoma models.

Viallard C, Perrot Y, Boudhraa Z, Jouberton E, Miot-Noirault E, Bonnet M, Besse S, Mishellany F, Cayre A, Maigne L, Rbah-Vidal L, D'Incan M, Cachin F, Chezal JM, Degoul F.

Eur J Dermatol. 2015 Jan-Feb;25(1):29-35. doi: 10.1684/ejd.2014.2481.

PMID:
25548082
4.

In vivo efficacy of melanoma internal radionuclide therapy with a 131I-labelled melanin-targeting heteroarylcarboxamide molecule.

Degoul F, Borel M, Jacquemot N, Besse S, Communal Y, Mishellany F, Papon J, Penault-Llorca F, Donnarieix D, Doly M, Maigne L, Miot-Noirault E, Cayre A, Cluzel J, Moins N, Chezal JM, Bonnet M.

Int J Cancer. 2013 Sep 1;133(5):1042-53. doi: 10.1002/ijc.28103. Epub 2013 Mar 18.

5.
6.
7.

Phage display library derived peptides that bind to human tumor melanin as potential vehicles for targeted radionuclide therapy of metastatic melanoma.

Howell RC, Revskaya E, Pazo V, Nosanchuk JD, Casadevall A, Dadachova E.

Bioconjug Chem. 2007 Nov-Dec;18(6):1739-48. Epub 2007 Oct 2.

PMID:
17907769
8.

Uptake in melanoma cells of N-(2-diethylaminoethyl)-2-iodobenzamide (BZA2), an imaging agent for melanoma staging: relation to pigmentation.

Mansard S, Papon J, Moreau MF, Miot-Noirault E, Labarre P, Bayle M, Veyre A, Madelmont JC, Moins N.

Nucl Med Biol. 2005 Jul;32(5):451-8.

PMID:
15982575
9.

Synthesis, in vitro binding and biodistribution in B16 melanoma-bearing mice of new iodine-125 spermidine benzamide derivatives.

Moreau MF, Papon J, Labarre P, Moins N, Borel M, Bayle M, Bouchon B, Madelmont JC.

Nucl Med Biol. 2005 May;32(4):377-84.

PMID:
15878507
10.

Melanosomal pH controls rate of melanogenesis, eumelanin/phaeomelanin ratio and melanosome maturation in melanocytes and melanoma cells.

Ancans J, Tobin DJ, Hoogduijn MJ, Smit NP, Wakamatsu K, Thody AJ.

Exp Cell Res. 2001 Aug 1;268(1):26-35.

PMID:
11461115
11.

Radioimmunotherapy of experimental human metastatic melanoma with melanin-binding antibodies and in combination with dacarbazine.

Revskaya E, Jongco AM, Sellers RS, Howell RC, Koba W, Guimaraes AJ, Nosanchuk JD, Casadevall A, Dadachova E.

Clin Cancer Res. 2009 Apr 1;15(7):2373-9. doi: 10.1158/1078-0432.CCR-08-2376. Epub 2009 Mar 17.

12.

Characterization of melanogenesis and morphogenesis of melanosomes by physicochemical properties of melanin and melanosomes in malignant melanoma.

Jimbow K, Miyake Y, Homma K, Yasuda K, Izumi Y, Tsutsumi A, Ito S.

Cancer Res. 1984 Mar;44(3):1128-34.

13.
14.

Radiolabeled melanin-binding peptides are safe and effective in treatment of human pigmented melanoma in a mouse model of disease.

Dadachova E, Moadel T, Schweitzer AD, Bryan RA, Zhang T, Mints L, Revskaya E, Huang X, Ortiz G, Nosanchuk JS, Nosanchuk JD, Casadevall A.

Cancer Biother Radiopharm. 2006 Apr;21(2):117-29.

PMID:
16706632
15.

Melanin affinity of N-(2-diethylaminoethyl)-4-iodobenzamide, an effective melanoma imaging agent.

Labarre P, Papon J, Moreau MF, Moins N, Bayle M, Veyre A, Madelmont JC.

Melanoma Res. 2002 Apr;12(2):115-21.

PMID:
11930107
16.

Melanin content of hamster tissues, human tissues, and various melanomas.

Watts KP, Fairchild RG, Slatkin DN, Greenberg D, Packer S, Atkins HL, Hannon SJ.

Cancer Res. 1981 Feb;41(2):467-72.

17.

Targeted alpha therapy for cancer.

Allen BJ, Raja C, Rizvi S, Li Y, Tsui W, Zhang D, Song E, Qu CF, Kearsley J, Graham P, Thompson J.

Phys Med Biol. 2004 Aug 21;49(16):3703-12.

PMID:
15446799
18.

Melanin as a potential target for radionuclide therapy of metastatic melanoma.

Dadachova E, Casadevall A.

Future Oncol. 2005 Aug;1(4):541-9. Review.

PMID:
16556030
19.

The degree of pigmentation modulates the radiosensitivity of human melanoma cells.

Kinnaert E, Morandini R, Simon S, Hill HZ, Ghanem G, Van Houtte P.

Radiat Res. 2000 Nov;154(5):497-502.

PMID:
11025646
20.

A human melanoma cell line established from xenograft in athymic mice.

Tveit KM, Fodstad O, Johannessen JV, Olsnes S.

Br J Cancer. 1980 May;41(5):724-33.

Supplemental Content

Support Center